Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Receives $10.59 Average Price Target from Brokerages

Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) has been given an average rating of "Reduce" by the twelve analysts that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $10.59.

A number of equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Truist Financial cut their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Evercore ISI lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a report on Monday, January 13th. StockNews.com initiated coverage on Walgreens Boots Alliance in a research report on Monday. They issued a "hold" rating for the company. Finally, Bank of America boosted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th.

Insider Buying and Selling

In related news, Chairman Stefano Pessina purchased 832,258 shares of the firm's stock in a transaction dated Sunday, April 27th. The shares were acquired at an average cost of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the purchase, the chairman now directly owns 145,621,079 shares of the company's stock, valued at $1,603,288,079.79. This trade represents a 0.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 17.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Brooklyn Investment Group boosted its holdings in Walgreens Boots Alliance by 21.1% in the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock valued at $44,000 after acquiring an additional 830 shares during the last quarter. First Financial Corp IN lifted its position in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares during the period. Central Pacific Bank Trust Division boosted its stake in shares of Walgreens Boots Alliance by 28.6% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,500 shares of the pharmacy operator's stock valued at $50,000 after purchasing an additional 1,000 shares during the last quarter. CWA Asset Management Group LLC raised its stake in shares of Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator's stock worth $120,000 after buying an additional 1,084 shares during the last quarter. Finally, Metis Global Partners LLC lifted its holdings in Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock valued at $222,000 after buying an additional 1,118 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Down 0.1 %

Walgreens Boots Alliance stock traded down $0.01 during mid-day trading on Thursday, hitting $10.99. 8,026,742 shares of the company's stock were exchanged, compared to its average volume of 21,023,639. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $18.83. The stock has a 50 day moving average of $10.97 and a two-hundred day moving average of $10.26. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market cap of $9.50 billion, a P/E ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. During the same period last year, the business earned $1.20 EPS. The firm's revenue was up 4.1% compared to the same quarter last year. As a group, analysts anticipate that Walgreens Boots Alliance will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.